HIGHLIGHTS
- who: Magdalena Kowalewicz-Kulbat and Camille Locht from the Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, University Lille, CNRS, Inserm, Lille, France have published the research work: Recombinant BCG to Enhance Its Immunomodulatory Activities, in the Journal: Vaccines 2022, 10, 827. of /2022/
- what: In this review the authors provide an overview of the different molecular engineering strategies adopted over the last three decades to the immune-modulatory potential of BCG. This study was followed up by a study in which . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.